Stryker LFIT V40 Femoral Head Recall
Stryker's LFIT Anatomic Cobalt Chromium V40 femoral heads are used in combination with a number of the company modular hip implants, including:
- Accolade TMZF
- Accolade 2 Stems
- Meridian Stems
- Citation Stems
Last August, Stryker issued an "Urgent Medical Device Recall Notification," after certain LFIT V40 femoral heads had been associated with an unusually high number of complaints involving taper-lock failure. Should this occur, patients may experience:
- Loss of mobility
- Adverse local tissue reaction
- Joint instability
- Bone fractures around the components
- Leg length discrepancy
- Need for revision surgery
The U.S. Food & Drug Administration (FDA) later designated Stryker's action a Class II recall, which indicates that the affected femoral heads may cause temporary or medically reversible adverse health consequences.
Last month, plaintiffs pursuing similar Stryker hip lawsuits in federal courts filed a petition with the U.S. Judicial Panel on Multidistrict Litigation seeking centralization of their claims in the U.S. District Court, District of Massachusetts. The January 13th petition noted that six such cases were already pending in federal courts around the country, and asserted that the litigation has the potential to include thousands of similar claims. Plaintiffs contend that centralization of the federal docket will "promote the just and efficient conduct of these actions." (In RE: Stryker Orthopaedics LFIT V40 Femoral Head Product Liability Litigation, MDL NO. 2768)
Compensation may be available to individuals who allegedly suffered pain, disability, and other complications resulting from the taper lock failure of a Stryker LFIT Anatomic CoCr V40 Femoral Head. To learn more about filing a Stryker hip lawsuit, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2017 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-jersey-stryker-hip-lawsuit-plaintiffs-seek-multi-county-designation-for-lfit-v40-femoral-head-claims-bernstein-liebhard-llp-reports-300405626.html
SOURCE Bernstein Liebhard LLP